From: PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival
All subtypes | TNBC | ||
---|---|---|---|
No. of patients | |||
All carcinomas | 401 | ||
Triple-negative carcinomas | 47 | 96 | |
Patient characteristics | |||
Mean age at diagnosis (range) (years) | 56 (39 - 78) | 62 (32-93) | |
Axillary lymph node positive (%) | 187 (46%) | 33 (35%) | |
Mean tumor size (range) (cm) | 2.4 (0.2-10.0) | 2.7 (0.8-18.0) | |
Histological type (%) | |||
Infiltrating ductal | 332 (82%) | 96 (100%) | |
Special type | 72 (18%) | 0 | |
Intrinsic subtype (%) | |||
Luminal | 281 (69%) | 0 | |
Her2-amplified | 51 (15%) | 0 | |
Triple-negative | 47 (17%) | 96 (100%) | |
Breast cancer deaths (%) | 141 (35%) | 21 (22%) |